Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
53 hedge funds and large institutions have $11.2M invested in Windtree Therapeutics Inc in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
187,350% more call options, than puts
Call options by funds: $7.5M | Put options by funds: $4K
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
10% more funds holding
Funds holding: 48 → 53 (+5)
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
40% less capital invested
Capital invested by funds: $18.8M → $11.2M (-$7.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$772K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$682K |
| 3 |
Millennium Management
New York
|
+$589K |
| 4 |
BC
Broadfin Capital
New York
|
+$410K |
| 5 |
LCM
Laurion Capital Management
New York
|
+$381K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.77M |
| 2 |
DM
Deerfield Management
New York
|
-$2.56M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$759K |
| 4 |
D.E. Shaw & Co
New York
|
-$49.5K |
| 5 |
Morgan Stanley
New York
|
-$28.1K |
WINT Hedge Fund Activity: Q4 2015 in Review
53 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2015, worth a combined $11.2M — down 40% from $18.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new WINT positions and 6 closed out — a net gain of 5 holders — while 11 added to existing stakes and 10 trimmed.
The largest buyer was Sabby Management, adding an estimated $772K. The largest seller was Fidelity Investments, cutting an estimated $2.77M.
- 53 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2015, up from 48 in Q3 2015.
- Funds reported $11.2M of Windtree Therapeutics Inc stock for Q4 2015, down 40% quarter-over-quarter.
- 11 funds opened new Windtree Therapeutics Inc positions in Q4 2015 and 6 closed out, a net change of +5 holders.
- The largest Windtree Therapeutics Inc buyer in Q4 2015 was Sabby Management, an estimated $772K added.
- The largest Windtree Therapeutics Inc seller in Q4 2015 was Fidelity Investments, an estimated $2.77M sold.
Based on aggregated 13F filings for Q4 2015.